Fisher Asset Management LLC Sells 88,758 Shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Fisher Asset Management LLC decreased its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 2.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,352,244 shares of the company’s stock after selling 88,758 shares during the period. Fisher Asset Management LLC owned about 33.19% of iShares U.S. Pharmaceuticals ETF worth $236,702,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Cultivar Capital Inc. bought a new position in iShares U.S. Pharmaceuticals ETF in the second quarter worth approximately $25,000. US Bancorp DE raised its position in iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock worth $27,000 after acquiring an additional 222 shares during the period. Rothschild Investment LLC bought a new position in iShares U.S. Pharmaceuticals ETF in the second quarter worth approximately $26,000. Mather Group LLC. bought a new position in iShares U.S. Pharmaceuticals ETF in the second quarter worth approximately $29,000. Finally, Assetmark Inc. raised its position in iShares U.S. Pharmaceuticals ETF by 100.0% in the third quarter. Assetmark Inc. now owns 432 shares of the company’s stock worth $31,000 after acquiring an additional 216 shares during the period.

iShares U.S. Pharmaceuticals ETF Trading Up 0.1 %

IHE opened at $68.46 on Tuesday. iShares U.S. Pharmaceuticals ETF has a 1-year low of $57.96 and a 1-year high of $72.94. The company has a market capitalization of $691.40 million, a PE ratio of 6.49 and a beta of 0.58. The firm’s 50 day simple moving average is $70.04 and its two-hundred day simple moving average is $68.77.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.